There are many pharmacologic therapies that are being used or considered for treatment of
coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence …

Background Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the
replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of …

Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …

Abstract Scope In January 2021, the ESCMID Executive Committee decided to launch a new
initiative to develop ESCMID guidelines on several COVID-19-related issues, including …

Importance It is unknown whether ivermectin, with a maximum targeted dose of 600 μg/kg,
shortens symptom duration or prevents hospitalization among outpatients with mild to …

Importance Ivermectin, an inexpensive and widely available antiparasitic drug, is prescribed
to treat COVID-19. Evidence-based data to recommend either for or against the use of …

High concentrations of ivermectin demonstrated antiviral activity against SARS-CoV-2 in
vitro. The aim of this study was to assess the safety and efficacy of high-dose ivermectin in …

Ivermectin is an antiparasitic drug being investigated for repurposing against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Ivermectin showed in vitro activity …

Molnupiravir is a β-d-N4-hydroxycytidine-5′-isopropyl ester (NHC) compound that exerts
antiviral activity against various RNA viruses such as influenza, SARS, and Ebola viruses …

Background The role of ivermectin in the treatment of COVID-19 is still under debate, yet the
drug has been widely used in some parts of the world, as shown by impressive market data …